Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-04-000380
Filing Date
2004-06-02
Accepted
2004-06-02 15:24:41
Documents
1
Period of Report
2004-06-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 10607
  Complete submission text file 0000904454-04-000380.txt   12628
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0103
Type: 4 | Act: 34 | File No.: 000-50767 | Film No.: 04844351
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50767 | Film No.: 04844350

Mailing Address
Business Address 675 MASSACHUSETTS AVE 14TH FLOOR CAMBRIDGE MA 02139 6173549311
CRITICAL THERAPEUTICS INC (Issuer) CIK: 0001145404 (see all company filings)

EIN.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations